Phio Pharmaceuticals
PHIO on Nasdaq. Market value $9m.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
What to watch out for
Read the warning sign in its own filings
This is not advice.
Who owns it
None of the long-term investors we follow own it. 24 funds in all.
Largest holders overall
- Jane Street Group$120,699
- Geode Capital Management$117,437Cut
- Vanguard Capital Management$96,619Added
- Nomura Asset Management International$51,000New
- Cetera Investment Advisers$48,688Added
- Citadel Advisors$48,329New
- Vanguard Fiduciary Trust$39,123
- Northern Trust$28,462Added
- TWO Sigma Investments, LP$22,039Cut
- XTX Topco$18,937Cut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- CVI Investments, Inc.Passive investorat least 9.9%0.0 pts(filed with 1 related holder)Since 30 September 2026
- Mitchell P. KopinPassive investorat least 9.1%+2.1 pts(filed with 2 related holders)Since 31 December 2025
- Orca Capital AGPassive investorSold down below 5%Since 8 December 2025
| Holder | Stake | Since | |
|---|---|---|---|
CVI Investments, Inc. Passive investor | at least 9.9%0.0 pts (filed with 1 related holder) | 30 September 2026 | |
Mitchell P. Kopin Passive investor | at least 9.1%+2.1 pts (filed with 2 related holders) | 31 December 2025 | |
Orca Capital AG Passive investor | Sold down below 5% | 8 December 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 4 insiders bought $140,478 of shares on the open market.
- Deming David HDirectorBought
- Date
- 13 November 2026
- Shares
- 3,000
- Price
- $0.83
- Value
- $2,500
- Deming David HDirectorBought
- Date
- 12 November 2026
- Shares
- 9,000
- Price
- $0.81
- Value
- $7,322
- Deming David HDirectorBought
- Date
- 11 November 2026
- Shares
- 5,200
- Price
- $0.84
- Value
- $4,358
- Deming David HDirectorBought
- Date
- 10 November 2026
- Shares
- 6,800
- Price
- $0.84
- Value
- $5,709
- Plott Ronald ToddDirectorBought
- Date
- 9 November 2026
- Shares
- 18,300
- Price
- $0.83
- Value
- $15,189
- Bitterman Robert JChairman, Pres. & CEO, DirectorBought
- Date
- 9 November 2026
- Shares
- 25,000
- Price
- $0.82
- Value
- $20,500
- Plott Ronald ToddDirectorBought
- Date
- 29 September 2026
- Shares
- 5,000
- Price
- $1.04
- Value
- $5,200
- Plott Ronald ToddDirectorBought
- Date
- 28 September 2026
- Shares
- 5,000
- Price
- $1.03
- Value
- $5,150
- BRADFORD PATRICIA ADirectorBought
- Date
- 24 September 2026
- Shares
- 6,500
- Price
- $1.01
- Value
- $6,583
- Bitterman Robert JChairman, Pres. & CEO, DirectorBought
- Date
- 22 September 2026
- Shares
- 2,000
- Price
- $1.03
- Value
- $2,058
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 13 November 2026 | Deming David H Director | Bought | 3,000 | $0.83 | $2,500 |
| 12 November 2026 | Deming David H Director | Bought | 9,000 | $0.81 | $7,322 |
| 11 November 2026 | Deming David H Director | Bought | 5,200 | $0.84 | $4,358 |
| 10 November 2026 | Deming David H Director | Bought | 6,800 | $0.84 | $5,709 |
| 9 November 2026 | Plott Ronald Todd Director | Bought | 18,300 | $0.83 | $15,189 |
| 9 November 2026 | Bitterman Robert J Chairman, Pres. & CEO, Director | Bought | 25,000 | $0.82 | $20,500 |
| 29 September 2026 | Plott Ronald Todd Director | Bought | 5,000 | $1.04 | $5,200 |
| 28 September 2026 | Plott Ronald Todd Director | Bought | 5,000 | $1.03 | $5,150 |
| 24 September 2026 | BRADFORD PATRICIA A Director | Bought | 6,500 | $1.01 | $6,583 |
| 22 September 2026 | Bitterman Robert J Chairman, Pres. & CEO, Director | Bought | 2,000 | $1.03 | $2,058 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in Phio Pharmaceuticals’ filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 5 Mar 2026, plus the 10-Q filed 5 Nov 2026 and 10 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”
Show the full paragraph
The Company has limited cash resources, has reported recurring losses from operations since inception, has negative operating cash flows and has not yet generated product revenues. As of September 30, 2026, the Company had cash and cash equivalents of approximately $ 10.6 million. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. Based on the Company's current operating plan and existing cash resources, management believes the Company may not have sufficient cash and cash equivalents to fund planned operations for at least the next 12 months from the date these condensed consolidated financial statements are released. The continuation of the Company as a going concern depends upon the Company’s ability to raise additional capital through an equity offering, debt offering and/or strategic opportunity to fund its operations. There can be no assurance that the Company will be successful in accomplishing these plans in order to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
From the 10-Q filed 5 November 2026, Part I, Item 1. Financial Statements. Read it in the filing
Changed auditor
Worth knowingThe company changed its auditor (the firm that checks its books) in the last two years.
“As a result of this process, on April 17, 2025, the Audit Committee approved the dismissal of BDO USA, P.C. (“BDO”) as the Company’s independent registered public accounting firm, effective immediately.”
From an 8-K filed 22 April 2025: Change of auditor. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.